Literature DB >> 9797461

Retrograde axonal transport of neurotrophins: differences between neuronal populations and implications for motor neuron disease.

S E Bartlett1, A J Reynolds, I A Hendry.   

Abstract

During development, neurons die if they do not receive neurotrophin support from the target cells they are innervating. Neurotrophins are delivered from the target to the cell bodies of the innervating neurons by interacting with specific receptors located on the nerve terminals and then together are retrogradely transported to the cell body. This process consists of a number of distinct events including endocytosis of neurotrophin and its receptor into coated vesicles; vesicle sorting followed by retrograde axonal transport to the cell body, where interaction of the activated receptor initiates a signalling cascade at the cell body that causes the survival response. It has recently been shown that the signalling molecules associated with retrograde transport differ between neuronal populations. In sympathetic but not sensory neurons, a wortmannin-sensitive molecule (phosphatidylinositol kinase) is essential for the retrograde transport of neurotrophins. In sensory but not sympathetic neurons, a rapamycin-sensitive molecule (pp70S6K) is associated with retrograde transport of neurotrophins. This is strong evidence that sympathetic and sensory neurons utilize different signalling pathways to perform the same cellular function; retrograde transport. These findings may provide clues to understanding neurological diseases, such as motor neuron disease, in which axonal transport is impaired specifically in motor neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797461     DOI: 10.1046/j.1440-1711.1998.00767.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

1.  HAP1 Is Required for Endocytosis and Signalling of BDNF and Its Receptors in Neurons.

Authors:  Yoon Lim; Linda Lin-Yan Wu; Si Chen; Ying Sun; Swarna Lekha Vijayaraj; Miao Yang; Larisa Bobrovskaya; Damien Keating; Xiao-Jiang Li; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

2.  Exercise attenuates age-associated changes in motoneuron number, nucleocytoplasmic transport proteins and neuromuscular health.

Authors:  Ashley Gillon; Kathrine Nielsen; Charlotte Steel; Jon Cornwall; Philip Sheard
Journal:  Geroscience       Date:  2018-05-07       Impact factor: 7.713

3.  Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1G93A mice.

Authors:  Atsushi Sawada; Shanshan Wang; Minyu Jian; Joseph Leem; Jesse Wackerbarth; Junji Egawa; Jan M Schilling; Oleksandr Platoshyn; Alice Zemljic-Harpf; David M Roth; Hemal H Patel; Piyush M Patel; Martin Marsala; Brian P Head
Journal:  FASEB J       Date:  2019-03-20       Impact factor: 5.191

4.  Axon and muscle spindle hyperplasia in the myostatin null mouse.

Authors:  Mohamed I Elashry; Anthony Otto; Antonios Matsakas; Salah E El-Morsy; Lisa Jones; Bethan Anderson; Ketan Patel
Journal:  J Anat       Date:  2011-02       Impact factor: 2.610

5.  HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.

Authors:  Ying Wang; Maryline Santerre; Italo Tempera; Kayla Martin; Ruma Mukerjee; Bassel E Sawaya
Journal:  Neuropharmacology       Date:  2017-02-14       Impact factor: 5.250

6.  Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits.

Authors:  M L Pearn; J M Schilling; M Jian; J Egawa; C Wu; C D Mandyam; M J Fannon-Pavlich; U Nguyen; J Bertoglio; M Kodama; S K Mahata; C DerMardirossian; B P Lemkuil; R Han; W C Mobley; H H Patel; P M Patel; B P Head
Journal:  Br J Anaesth       Date:  2018-02-15       Impact factor: 9.166

7.  Local translation in primary afferents and its contribution to pain.

Authors:  Jenna R Gale; Jeremy Y Gedeon; Christopher J Donnelly; Michael S Gold
Journal:  Pain       Date:  2022-04-19       Impact factor: 7.926

Review 8.  ProNGF and Neurodegeneration in Alzheimer's Disease.

Authors:  Margaret Fahnestock; Arman Shekari
Journal:  Front Neurosci       Date:  2019-02-22       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.